Skip to main content
Top
Published in: Critical Care 5/2010

01-10-2010 | Letter

Beta-lactam antibiotics in continuous infusion in critically ill patients

Authors: Axel Jeurissen, Robert Rutsaert

Published in: Critical Care | Issue 5/2010

Login to get access

Excerpt

We read with great interest Taccone and colleagues' article [1], published in a recent issue of Critical Care, on the insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock. While we fully agree with the authors' findings, we would like to offer some remarks. …
Literature
1.
go back to reference Taccone FS, Laterre PF, Dugernier T, Spapen H, Delattre I, Witebolle X, De Backer D, Layeux B, Wallemacq P, Vincent JL, Jacobs F: Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock. Crit Care. 2010, 14: R126-10.1186/cc9091.PubMedCentralCrossRefPubMed Taccone FS, Laterre PF, Dugernier T, Spapen H, Delattre I, Witebolle X, De Backer D, Layeux B, Wallemacq P, Vincent JL, Jacobs F: Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock. Crit Care. 2010, 14: R126-10.1186/cc9091.PubMedCentralCrossRefPubMed
2.
go back to reference Vincent JL, Rello J, Marshal J, Eliezer S, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K, for the EPIC II Group of Investigators: International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009, 302: 2323-2329. 10.1001/jama.2009.1754.CrossRefPubMed Vincent JL, Rello J, Marshal J, Eliezer S, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K, for the EPIC II Group of Investigators: International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009, 302: 2323-2329. 10.1001/jama.2009.1754.CrossRefPubMed
3.
go back to reference Belgian Isepamycin Multicentre Group: Comparative in vitro activity of isepamycin and other antibiotics against gram-negative bacilli from intensive care units (ICU) in Belgium. Acta Clin Belg. 2001, 56: 307-315.CrossRef Belgian Isepamycin Multicentre Group: Comparative in vitro activity of isepamycin and other antibiotics against gram-negative bacilli from intensive care units (ICU) in Belgium. Acta Clin Belg. 2001, 56: 307-315.CrossRef
4.
go back to reference Roberts JA, Lipman J, Blot S, Rello J: Better outcomes through continuous infusion of time-dependent antibiotics to critically ill patients?. Curr Opin Crit Care. 2008, 14: 390-396. 10.1097/MCC.0b013e3283021b3a.CrossRefPubMed Roberts JA, Lipman J, Blot S, Rello J: Better outcomes through continuous infusion of time-dependent antibiotics to critically ill patients?. Curr Opin Crit Care. 2008, 14: 390-396. 10.1097/MCC.0b013e3283021b3a.CrossRefPubMed
5.
go back to reference Page MG, Heim J: Prospects for the next anti-Pseudomonas drug. Curr Opin Pharmacol. 2009, 9: 558-565. 10.1016/j.coph.2009.08.006.CrossRefPubMed Page MG, Heim J: Prospects for the next anti-Pseudomonas drug. Curr Opin Pharmacol. 2009, 9: 558-565. 10.1016/j.coph.2009.08.006.CrossRefPubMed
6.
go back to reference Riou M, Carbonnelle S, Avrain L, Mesaros N, Pirnay JP, Bilocq F, De Vos D, Simon A, Piérard D, Jacobs F, Dediste A, Tulkens P, Van Bambeke F, Glupczynski Y: In vivo development of antimicrobial resistance in Pseudomonas aeruginosastrains isolated from the lower respiratory tract of intensive care unit patients with nosocomial pneumonia and receiving antipseudomonal therapy. Int J Antimicrob Agents. 2010, Riou M, Carbonnelle S, Avrain L, Mesaros N, Pirnay JP, Bilocq F, De Vos D, Simon A, Piérard D, Jacobs F, Dediste A, Tulkens P, Van Bambeke F, Glupczynski Y: In vivo development of antimicrobial resistance in Pseudomonas aeruginosastrains isolated from the lower respiratory tract of intensive care unit patients with nosocomial pneumonia and receiving antipseudomonal therapy. Int J Antimicrob Agents. 2010,
7.
go back to reference Lorente L, Jiménez A, Palmero S, Jiménez JJ, Iribarren JL, Santana M, Martin MM, Mora ML: Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administrated by continuous or intermittent infusion: a retrospective, nonrandomized, open-label, historical chart review. Clin Ther. 2007, 29: 2433-2439. 10.1016/j.clinthera.2007.11.003.CrossRefPubMed Lorente L, Jiménez A, Palmero S, Jiménez JJ, Iribarren JL, Santana M, Martin MM, Mora ML: Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administrated by continuous or intermittent infusion: a retrospective, nonrandomized, open-label, historical chart review. Clin Ther. 2007, 29: 2433-2439. 10.1016/j.clinthera.2007.11.003.CrossRefPubMed
Metadata
Title
Beta-lactam antibiotics in continuous infusion in critically ill patients
Authors
Axel Jeurissen
Robert Rutsaert
Publication date
01-10-2010
Publisher
BioMed Central
Published in
Critical Care / Issue 5/2010
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc9288

Other articles of this Issue 5/2010

Critical Care 5/2010 Go to the issue